Published research on Thymosin Beta-4 includes Phase II clinical trials in wound healing that showed significant improvement compared to placebo
Fujisaki N, Kosaki Y, Nojima T, Higaki T, Yamada T, Koga H, Gochi A, Naito H, Nakao A (2020) Glycogenic hepatopathy following attempted suicide by long-acting insulin overdose in patient with type 1 diabetes
4.2 Targeting Gln metabolism to inhibit tumor proliferation 4.2.1 Inhibition of Gln uptake Tumor survival and proliferation are heavily dependent on Gln, a hydrophilic amino acid that must be transported into tumor cells by transmembrane proteins, such as SLC1A5, SLC6A14, and SLC38A1/2
However, BPC 157 is relatively stable and small dose ranged between ng-g/ml or ng-g/kg is already effective on promoting tissue injury healing and angiogenesis in many animal studies 4,27,28,29,30